Bill Texts: NJ S1590 | 2018-2019 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2018-02-05 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1590 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2018-02-05HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey S1590

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey S1590 currently on file.

Social Comments on NJ S1590

feedback